These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16847412)

  • 1. Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients.
    Banasch M; Goetze O; Knyhala K; Potthoff A; Schlottmann R; Kwiatek MA; Bulut K; Schmitz F; Schmidt WE; Brockmeyer NH
    AIDS; 2006 Jul; 20(11):1554-6. PubMed ID: 16847412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
    Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A
    J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
    Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H
    Antivir Ther; 2007; 12(1):97-105. PubMed ID: 17503753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
    Calmy A; Bloch M; Wand H; Delhumeau C; Finlayson R; Rafferty M; Norris R; Hirschel B; Cooper DA; Carr A;
    HIV Med; 2010 Sep; 11(8):493-501. PubMed ID: 20236365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir.
    McComsey GA; O'Riordan M; Choi J; Libutti D; Rowe D; Storer N; Harrill D; Gerschenson M
    Antivir Ther; 2012; 17(2):347-53. PubMed ID: 22293126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.
    Walker UA; Venhoff N
    Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic.
    Banasch M; Knyhala K; Kollar S; Serova K; Potthoff A; Schlottmann R; Schmidt WE; Brockmeyer NH; Goetze O
    Eur J Med Res; 2008 Sep; 13(9):401-8. PubMed ID: 18948231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices.
    McComsey GA; O'Riordan M; Setzer B; Lebrecht D; Baron E; Walker UA
    Eur J Clin Nutr; 2008 Aug; 62(8):1031-7. PubMed ID: 17538545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
    Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
    Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial damage in adipose tissue of untreated HIV-infected patients.
    Garrabou G; López S; Morén C; Martínez E; Fontdevila J; Cardellach F; Gatell JM; Miró O
    AIDS; 2011 Jan; 25(2):165-70. PubMed ID: 21150553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
    De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
    Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
    Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
    Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of oral uridine in mitochondrial toxicity.
    Walker UA; Langmann P; Miehle N; Zilly M; Klinker H; Petschner F
    AIDS; 2004 Apr; 18(7):1085-6. PubMed ID: 15096820
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis and management of lipoatrophy.
    Tungsiripat M; McComsey G
    Curr HIV/AIDS Rep; 2008 May; 5(2):55-63. PubMed ID: 18510890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.
    Brinkman K
    Clin Infect Dis; 2000 Jul; 31(1):167-9. PubMed ID: 10913416
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO; Grattagliano I; Minerva F; Pollice S; Palasciano G; Portincasa P
    J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice.
    Lebrecht D; Vargas-Infante YA; Setzer B; Kirschner J; Walker UA
    Hepatology; 2007 Jan; 45(1):72-9. PubMed ID: 17187420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.